Related Experiment Video
Updated: Aug 14, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 10, 2011
Incidence of glycopeptide hetero-intermediate Staphylococcus aureus strains in Maltese hospitals
M A Borg1, R Zerafa, D Morrison
1Infection Control Unit, St Luke's Hospital, Guardamangia, Malta. michael.a.borg@gov.mt
Abstract:
The incidence of hetero-intermediate glycopeptide susceptibility among Staphylococcus aureus isolates in Malta, a country with a high incidence of methicillin resistance, was studied by screening 454 non-repetitive S. aureus isolates on teicoplanin-supplemented agar plates, followed by Etests and genotypic studies. All strains were susceptible to vancomycin, but four (0.88%) exhibited teicoplanin MICs of > 12 mg/L. High methicillin-resistant S.aureus endemicity was not an accurate predictor of the emergence of non-susceptibility to glycopeptides.
Insights
High rates of methicillin-resistant Staphylococcus aureus do not predict reduced susceptibility to glycopeptides. This study found low incidence of hetero-intermediate glycopeptide susceptibility in Malta despite high MRSA rates.
Area of Science:
- Microbiology
- Infectious Diseases
- Clinical Pharmacy
Background:
- High prevalence of Methicillin-Resistant Staphylococcus aureus (MRSA) in Malta.
- Glycopeptides like vancomycin and teicoplanin are critical for treating MRSA infections.
- Emergence of glycopeptide resistance is a significant public health concern.
Purpose of the Study:
- To investigate the incidence of hetero-intermediate glycopeptide susceptibility in Staphylococcus aureus isolates in Malta.
- To determine if high MRSA endemicity predicts the emergence of reduced glycopeptide susceptibility.
Main Methods:
- Screening of 454 non-repetitive S. aureus isolates using teicoplanin-supplemented agar.
- Further characterization using Etests for Minimum Inhibitory Concentrations (MICs).
- Genotypic analysis to confirm findings.
Main Results:
- All isolates were susceptible to vancomycin.
- Four isolates (0.88%) displayed teicoplanin MICs greater than 12 mg/L, indicating hetero-intermediate susceptibility.
- High MRSA endemicity in Malta did not correlate with increased glycopeptide non-susceptibility.
Conclusions:
- The emergence of hetero-intermediate glycopeptide susceptibility in S. aureus is low in Malta.
- High MRSA rates are not a reliable predictor for the development of glycopeptide resistance.
- Continued surveillance for antimicrobial resistance is crucial.
Related Concept Videos
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Rapid Identification of Pathogens
Staphylococcal Skin Infections
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance

